72.11.Z - Research and experimental development on biotechnology
20.12.Z - Manufacture of dyes and pigments
20.14.Z - Manufacture of other organic basic chemicals
20.15.Z - Manufacture of fertilisers and nitrogen compounds
20.20.Z - Manufacture of pesticides and other agrochemical products
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
62.01.Z - Computer programming activities
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | -726,4 | ||
Gross profit (loss) | -0,1 | 0,1 | 0,2 | 191,5 |
EBITDA | 0 | -79,9 | ||
Short time liabilities | 0,1 | 0 | 0,1 | 719 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 0,7 | 0,7 | 0,9 | 28,9 |
Operating profit (EBIT) | -0,1 | -196 | ||
Assets | 1,1 | 1 | 1,3 | 26,5 |
Net profit (loss) | -0,1 | 0,1 | 0,2 | 199,2 |
Cash | 0 | 122,8 | ||
Liabilities and provisions for liabilities | 0,4 | 0,3 | 0,2 | -12,1 |
Net income from sale | 0,3 | 0,4 | 0,5 | 4,3 |
Working assets | 0,6 | 0,5 | 0,8 | 50,9 |
Other income costs | 0,1 | 0 | 0 | 254 786,7 |
Depreciation | 0,1 | 0 | 0 | -74,2 |
% | % | % | p.p. | |
Profitability of capital | -11,4 | 9,6 | 22,4 | 12,8 |
Equity capital to total assets | 60,5 | 71,6 | 73 | 1,4 |
Gross profit margin | -29 | 16,8 | 46,9 | 30,1 |
EBITDA Margin | 14,8 | -27,6 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 164 | 7 | 59 | 52 |
Current financial liquidity indicator | 4.9543585777282715 | 59.69636535644531 | 10.999210357666016 | -48,7 |
Net dept to EBITDA | -0.04555549845099449 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane